2016 Oct 19
Cryoablation: Freezing away breast cancers
Rache Simmons, M.D., discusses a new non-surgical deep-freezing treatment for breast cancer. Read more
2016 Oct 17
Study finds what could be a key to prostate cancer progression
Mark Rubin, M.D., discusses the findings of a study of DNA-repair gene mutations in predicting invasive prostate cancer. Read more
2016 Oct 17
Chemotherapy drives treatment resistance in bladder cancer
While chemotherapy kills the most common type of bladder cancer, urothelial cancer, it also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant, according to Bishoy Faltas and colleagues. Read more
2016 Oct 10
Do I Have a Hidden Cancer?
A profile of Francis Barany, Ph.D., and some of his cancer detection tests. Read more
2016 Oct 10
Gene identified that drives aggressive prostate cancer
David Rickman, Ph.D., and colleagues have identified a gene that appears to regulate the change from prostate adenocarcinoma to neuroendocrine prostate cancer. Read more
2016 Oct 08
Alisertib may benefit certain patients with neuroendocrine prostate cancer
Alisertib monotherapy may be effective in certain patients with clinical or pathologically defined neuroendocrine prostate cancer, according to Himisha Beltran, M.D. Read more
2016 Oct 07
Chasing after ‘Compassionate Use’
Jeffrey Greenfield, M.D., Ph.D., speaks out about the need for wider - and speedier - use of the FDA compassionate use exception. Read more
2016 Oct 05
Pricey new treatment roils issues of how to treat prostate cancer
Drs. Jim Hu and Art Sedrakyan comment on the use of high-intensity focused ultrasound for prostate cancer treatment. Read more
2016 Sep 28
Weill Cornell, New York Genome Center Win NCI Grant to Support New TCGA Phase
A new collaboration will be formed to help further data analysis for the Cancer Genome Atlas project, thanks to a $490,000 grant from the National Cancer Institute. Read more
2016 Sep 28
Believe in Brooke: Finding peace with DIPG
A community has rallied around an 8-year-old with pediatric brain cancer, and the doctor who has saved her life so far with his experimental treatment. Read more
2016 Sep 28
Freezing technique is an effective alternative to lumpectomy for early stage breast cancer, study finds
A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers, according to Rache Simmons, M.D. Read more
2016 Sep 27
New drugs, immuno-oncology advances gastric cancer treatment paradigm
Immuno-oncology and the classification of subtypes of gastric cancer could greatly advance treatment efficacy and variation, according to Manish A. Shah, M.D. Read more
2016 Sep 26
Collaborative MDS research yields world-class results
The Weill Cornell Medicine Leukemia Program is part of collaborative research into myelodysplastic syndromes (MDS). Read more
2016 Sep 21
We Are Weill Cornell Medicine: Dr. Olivier Elemento
Olivier Elemento, Ph.D., is a featured faculty member in the #WeAreWCM campaign. Read more
2016 Sep 21
Moneyball could offer winning strategy for drug development
Researchers from the lab of Olivier Elemento, Ph.D., have developed a promising new AI tool that better predicts which drug candidates are likely to be too toxic. Read more
2016 Sep 20
Five questions for Harold Varmus
Harold Varmus, M.D., reflects on the state of medical research and the public's understanding of it, as well as politics. Read more
2016 Sep 20
Cancer Care: The Next Generation
Several Meyer Cancer Center faculty are featured in this half-hour television special on cancer. Read more
2016 Sep 19
The impact of Tecentriq to treat patients with advanced bladder cancer
The immunotherapy Tecentriq (atezolizumab) has been found to be non-toxic and has demonstrated a major survival advantage in patients with metastatic urothelial bladder cancer, according to David Nanus, M.D. Read more
2016 Sep 19
The cooperation that causes cancer
Ari Melnick, M.D., has uncovered the mechanisms by which B-cells can transform to cause cancer, and found that it requires a special cooperation between regulatory protein EZH2 and transcription protein BCL6. Read more
2016 Sep 19
The height of dedication
Matthew Bernstein, 16, is contributing to a cure for the cancer that claimed his brothers life. Read more
